What's Happening?
Researchers at the California Institute of Technology have discovered how viruses that infect bacteria can shut down MurJ, a protein crucial for building bacterial cell walls. This discovery, published in Nature, highlights MurJ as a promising new antibiotic
target. The study, led by graduate student Yancheng Evelyn Li and Professor Bil Clemons, reveals that different viruses have evolved separate proteins that block MurJ in the same way. This finding is significant as bacteria are rapidly developing resistance to existing antibiotics, creating a public health crisis. The research focuses on the peptidoglycan biosynthesis pathway, which is unique to bacteria and an attractive target for new antibiotics.
Why It's Important?
The discovery of a bacterial kill switch is crucial in the fight against antibiotic-resistant bacteria, which pose a significant threat to public health. In the U.S. alone, tens of thousands of people die annually from antibiotic-resistant infections. The identification of MurJ as a target for new antibiotics could lead to the development of drugs that effectively combat these superbugs. The study demonstrates the potential of using bacteriophages, viruses that infect bacteria, to identify new antibiotic targets. This approach could lead to the discovery of additional biological insights and new therapeutic strategies.
What's Next?
The research team plans to continue exploring the potential of MurJ as a drug target, leveraging the discovery of single-gene lysis proteins (Sgls) that inhibit MurJ. By studying the genomes of bacteriophages, researchers hope to uncover more Sgls and develop new antibiotics. The study underscores the importance of basic biological research in addressing medical challenges and highlights the need for continued support to translate these findings into practical treatments. The convergence of different evolutionary paths targeting MurJ suggests that it is a viable target for future drug development.
